Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novel polo-like kinase inhibitors developed at GSK

Oct. 19, 2004

Ranbaxy scientists describe new iminosugar-based anticancer agents

Oct. 19, 2004

New indole-containing oxazolidinone antibacterial agents identified at Pfizer

Oct. 18, 2004

New benzofurans acting as 5-HT reuptake inhibitors and 5-HT receptor ligands

Oct. 18, 2004

Neurogen presents novel GABA-A receptor modulators

Oct. 18, 2004

Antagonists of denatured collagen type IV and their use as antiangiogenic agents

Oct. 18, 2004

Novel PPAR agonists and their use described by Pfizer researchers

Oct. 18, 2004

New analgesic vanilloid VR1 antagonists discovered at Merck

Oct. 18, 2004

Novel vasopressin V1a receptor antagonists and their use in dysmenorrhea

Oct. 18, 2004

Encysive presents new urotensin II/CCR9 antagonists and their use

Oct. 15, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...